Biotracs ABP-2000 G-3 receives FDA approval

MIAMI, FL-April 15, 2002-Biotrac recently received FDA approval for it Ambulatory Blood Pressure Monitor the ABP-2000 G-3.

FOR IMMEDIATE RELEASE

CONTACT:
Mr. Jaime Guttman
Biotrac, Inc.
(509) 267-2283
sales@biotracmed.com

Biotracs ABP-2000 G-3 receives FDA approval

MIAMI, FL-April 15, 2002-Biotrac recently received FDA approval for it Ambulatory Blood Pressure Monitor the ABP-2000 G-3. This device is perhaps the most advanced in the market featuring a unique linear deflation system combined with the most advanced software to program the unit and analyze results.

Biotrac, one of the first manufacturers of Ambulatory Blood Pressure Monitors (ABPMs) has been a leader in the industry by providing a combination of cutting edge technology with strict quality controls to deliver reliable monitoring devices; that can be used even under rugged circumstances for extended periods of time.

Biotracs ABP 2000 is one of the few devices in the market to receive the prestigious British Hypertension Society Approval. This certifies that the device has met the highest standards for the diagnose of hypertension. In addition to meeting these standards, Biotrac is developing additional methods to further increase the accuracy and the reliability of its devices.

Biotrac is located in Miami, Florida. The company strives to provide top quality monitoring products with the use of the most advanced technologies. For additional information on Biotrac, the products that they offer, or to request copies of the published studies call (509) 267-2283 or send an email to sales@biotracmed.com.

END